Clinical Trials

Synchron reports positive results from Command study of its BCI system

Brain-computer interface (BCI) developer Synchron said there were no serious adverse events in its 12-month Command study, which also showed reliable performance of the...

Toro Neurovascular’s catheter trial begins with first patient in Japan

Toro Neurovascular announced the successful treatment of the first patient in a first-in-man clinical trial of its Toro 88 SuperBore Aspiration Catheter for acute...

Hyperfine’s Swoop MRI system trumps standard MRIs in interim study

Hyperfine has presented positive interim data from the ACTION PMR study, demonstrating that its magnetic resonance brain imaging (MRI) Swoop system offers faster time-to-scan...

DermaSensor’s skin cancer detection device helps clinicians in published study

US-based DermaSensor has announced a newly published study showing that its AI-powered device can improve a primary care physician’s ability to assess moles of...

Sparta Biomedical implants Ormi device in first-in-human trial

Medical device company Sparta Biomedical has announced the successful implantation of its Ormi device in a first-in-human clinical trial. Designed to treat knee osteoarthritis, the...

Alio starts trial to expand label for remote monitoring device

Alio plans to increase the use case for its wearable remote monitoring SmartPatch technology to monitor health metrics in dialysis patients without vascular accesss...

CVRx touts positive two-year data for heart failure neuromodulation device

Building on long-term data announced earlier this year, CVRx has reported durable improvements in heart failure patients with its Barostim device over 24 months. The...

iRhythm has positive post-market study results for next-gen Zio

iRhythm Technologies announced initial research findings on its Zio monitor’s post-market, real-world performance. The company presented the data on its next-generation long-term continuous monitoring...

ExThera Medical’s OSCAR I Study enrols first pancreatic cancer treatment patient

ExThera Medical’s OSCAR I Study (ONCObind CTC Removal Study), aimed at treating Metastatic Pancreatic Ductal Adenocarcinoma (PDAC), has enrolled the first patient at OU...
1...141516...58Page 15 of 58

Latest articles